Jul 25, 2020 by Amar KhatriIs CRISPR Therapeutics Stock a Buy?The gene-editing pioneer is a favorite among biotech investors and its stock is hitting new highs.
Jul 14, 2020 by Amar Khatri2 Top Cancer Treatment Stocks To Watch In JulyThese hidden gems have the potential to deliver significant returns to their shareholders over the long run.
Jul 6, 2020 by Amar KhatriThese 2 Pharma Stocks Could Be Top Stocks in 2020These pharma stocks are undervalued, and could be solid picks over the long term.
Jul 5, 2020 by Amar KhatriIs Dynavax Technologies Stock a Buy?This stock has the potential to break new highs with its key hepatitis B vaccine and emerging vaccine-adjuvant platform for COVID-19 vaccines.
Jul 1, 2020 by Amar Khatri2 Biotech Stocks That Could Soar in 2020These companies offer promising pipelines that could deliver in the long term.
Jun 24, 2020 by Amar KhatriBetter Buy: Illumina vs. Guardant HealthWhich stock wins in a matchup between these two healthcare stocks?
Jun 16, 2020 by Amar Khatri2 Top Cancer Treatment Stocks to Buy in JuneIf you have cash to spare, these cancer stocks are set to soar.
Jun 10, 2020 by Amar Khatri3 Drug Stocks That Could Soar in 2020Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.
Jun 9, 2020 by Amar KhatriIs Aurinia Pharmaceuticals Stock a Buy?This biopharma’s drug could be a home run for investors.
Jun 3, 2020 by Amar KhatriBetter Buy: CRISPR Therapeutics vs. IntelliaWhich gene editing stock wins this matchup?
Jun 2, 2020 by Amar KhatriIs Acadia Pharmaceuticals a Buy?A strong Q1 performance set the tone, but commitment to its strategy will be key to drive the stock higher.
May 19, 2020 by Amar KhatriIs Amarin Stock a Buy?Record revenues, international growth, and a potential legal strategy may provide upside.
May 12, 2020 by Amar KhatriIs Exact Sciences Stock a Buy?Q1 results were mixed, but the company’s strategy may be key for top-line growth ahead.
Apr 29, 2020 by Amar KhatriIs Catalyst Pharmaceuticals a Buy?Several catalysts could drive this biopharma higher, but there are some significant risks ahead, too.
Apr 23, 2020 by Amar KhatriYour 2 Top Profit Opportunities in 2020These two underrated biotech stocks have the potential to soar.
Apr 16, 2020 by Amar KhatriIs Exelixis a Buy?Cheap and ready to outperform, this under-the-radar biotech stock could be a winner.
Apr 8, 2020 by Amar KhatriIs BioMarin Pharmaceutical Stock a Buy?Is this a prime opportunity for investors to buy the gene therapy drugmaker?
Mar 12, 2020 by Amar KhatriThis 1 Stock Is a Good Buy During the Coronavirus Sell-OffAcadia Pharmaceuticals' track record of success and strong pipeline offers an attractive long-term opportunity for investors, especially at a depressed price.
Mar 2, 2020 by Amar KhatriCan Halozyme Therapeutics Continue Its Momentum in 2020?The biopharma's strategic moves in 2019 may set the company up for long term growth.
Mar 1, 2020 by Amar KhatriHere's Why Clovis Oncology Has Upside Potential in 2020The cancer-drug maker has a novel medicine that may provide growth opportunities in other areas of cancer.
